Inventor
Rumana RASHID
Inventor
US
Overview
Patents· 31 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides34%
A61KPreparations for medical, dental or toiletry purposes30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C12NMicroorganisms or enzymes12%
PatentTitleYear
12,509,495LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domains202512,448,423Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains202512,415,849Heterodimeric proteins202512,359,002Heterodimeric antibodies that bind CD3 and tumor antigens202512,239,688IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof202512,234,270IL-12 heterodimeric Fc-fusion proteins202512,129,309Heterodimeric antibodies that bind CD3 and CD38202412,054,545Heterodimeric antibodies that bind somatostatin receptor 2202412,006,345Untargeted and targeted IL-10 Fc-fusion proteins202411,981,717Engineered IL-2 Fc fusion proteins202411,945,880Heterodimeric antibodies that bind CD3 and tumor antigens202411,932,675PD-1 targeted IL-15/IL-15Ra Fc fusion proteins with improved properties202411,859,011Heterodimeric antibodies that bind CD3 and tumor antigens202411,851,466Targeted IL-12 heterodimeric Fc-fusion proteins202311,814,423Heterodimeric proteins202311,718,667Optimized antibody variable regions202311,673,972Heterodimeric antibodies that bind CD3 and tumor antigens202311,655,277IL-12 heterodimeric Fc-fusion proteins202311,634,506Heterodimeric proteins202311,618,776Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains202311,584,794Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments202311,524,991PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof202211,505,595TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains202211,472,890Heterodimeric antibodies that bind ENPP3 and CD3202211,377,477PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof202211,358,999IL-12 heterodimeric Fc-fusion proteins202211,352,442Heterodimeric antibodies that bind CD3 and CD38202211,319,355Engineered IL-2 Fc fusion proteins202211,299,554Heterodimeric proteins202211,225,521Heterodimeric antibodies that bind somatostatin receptor 2202211,225,528Heterodimeric antibodies that bind CD3 and tumor antigens2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to XENCOR INC (31)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to GENENTECH INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| XENCOR INC | 31 | 2022–2025 |
| GENENTECH INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 31 | 2022–2025 |